MLEC Moolec Science: יתרת חוב לטווח ארוך של החברה

This chart of the Moolec Science SA (MLEC) market price illustrates the dynamics of a leader in creating animal proteins within GMO crops, whose advantage is secured by patents on peas and soy. The company is currently scaling its B2B platform for alternative meat sales, with the metric standing at 0.00. Business development is constrained by strict food safety regulations and prolonged field yield tests.

Long-term liabilities aggregate a combination of credit lines and loans with maturities exceeding twelve months, determining strategic financial stability and the cost of capital. By analyzing the trajectory of the corporation's long-term loans and borrowings, an investor can assess the ability of Moolec Science SA to sustain investments in plant proteins amid moderate demand cyclicality and a potential consumer shift toward cheaper alternatives.